Funding agency DST

Start date March 27, 2023

End Date None

Duration None

Disease category Hereditary Tyrosinemia type 1

Type of study Invitro study

Type of data Quantitative data

Aims of objective • To deliver a drug compound/new process/formulation at affordable cost • At present monthly cost of the imported drug is approximately Rs 50,000/-to 2,00,000/-. • The aim is to process the drug Nitisinone from cheaper starting materials and environment friendly reagents which would be improved than previous processes.

Keyword Nitisinone, Alkaptonuria, Hereditary Tyrosinemia-1

Description None

Total Sanctioned budget None